US filing analysis · 10-Q
Sorted by SEC acceptance time (filing date when unavailable). Page 2 · 30 shown · up to 30 per page
FITB
The company said it closed its all-stock merger with Comerica Incorporated, valued at about $12.7 billion, on February 1, 2026, and that the acquisition and its integration affected the comparability of results for the 3-month and 9-month periods ended September 30, 2026.
US filing analysisUS10-Q · Quarterly reportPublished Nov 3, 2026 (UTC)SEC filing date Nov 3, 2026
Fifth Third BancorpFITB$49.39-2.87%
APTV
The company said net sales for the 3 months and 9 months ended September 30, 2026 were $3.2 billion and $9.5 billion, respectively, up 2% from the same periods in 2025. It said volumes rose 2% in both periods, and that volume growth in North America and Asia Pacific was partly offset by declines in Europe.
US filing analysisUS10-Q · Quarterly reportPublished Nov 3, 2026 (UTC)SEC filing date Nov 3, 2026
AptivAPTV$35.33-5.43%
KEY
KeyCorp said net interest income (TE) for Q3 2026 was $1.31 billion and the net interest margin was 2.95%. Compared with Q3 2025, net interest income (TE) rose $115 million and the net interest margin rose 20 basis points. The company cited lower deposit costs, the reinvestment of proceeds from maturing low-yielding investment securities and fixed-rate swaps, a larger balance sheet, and a higher mix of commercial and industrial loans as factors.
US filing analysisUS10-Q · Quarterly reportPublished Nov 3, 2026 (UTC)SEC filing date Nov 3, 2026
KeyCorpKEY$19.45-2.90%
IFF
IFF said its Q3 2026 sales rose $73 million (4%) from $1.869 billion a year earlier to $1.942 billion. The company cited consolidated volume growth of 5%, including volume growth across all segments, as the driver.
US filing analysisUS10-Q · Quarterly reportPublished Nov 3, 2026 (UTC)SEC filing date Nov 3, 2026
International Flavors & FragrancesIFF$79.62+1.28%
JPM
The company said its net income for Q3 2026 rose 6% to $15.3 billion, with earnings per share of $5.57, ROE of 17% and ROTCE of 20%. It also said the results included a net investment securities loss of $658 million ($498 million after tax) in Treasury and CIO.
US filing analysisUS10-Q · Quarterly reportPublished Nov 3, 2026 (UTC)SEC filing date Nov 3, 2026
JPMorgan ChaseJPM$310.53-3.03%
DOC
The company said it issued 48,300,000 shares of Class A-1 common stock in the Janus Living IPO in March 2026, generating total gross proceeds of $966 million (before $65 million in underwriting fees). It said the June follow-on offering in June generated $719 million, and the August follow-on offering in August generated $534 million.
US filing analysisUS10-Q · Quarterly reportPublished Nov 3, 2026 (UTC)SEC filing date Nov 3, 2026
Healthpeak PropertiesDOC$19.24+0.26%
GNRC
The company said Commercial & Industrial segment total net sales for Q3 2026 rose about 28% to $553.0 million from $432.4 million a year earlier, while Residential segment sales rose about 9% to $744.1 million from $685.0 million.
US filing analysisUS10-Q · Quarterly reportPublished Nov 3, 2026 (UTC)SEC filing date Nov 3, 2026
GeneracGNRC$193.22-5.79%
COF
The company reported net income of $3.5 billion ($5.61 per diluted common share) on total net revenue of $16.3 billion for Q3 2026. For Q3 2025, net income was $3.2 billion ($4.83 per diluted common share) and total net revenue was $15.4 billion.
US filing analysisUS10-Q · Quarterly reportPublished Nov 3, 2026 (UTC)SEC filing date Nov 3, 2026
Capital OneCOF$178.66-1.71%
AES
The company said that its net income for Q3 2026 rose $10 million, from $517 million to $527 million, and that its Adjusted EBITDA, a non-GAAP measure, increased $260 million, from $830 million to $1,090 million. Net income for the 9 months to date rose from $294 million to $1,189 million.
US filing analysisUS10-Q · Quarterly reportPublished Nov 3, 2026 (UTC)SEC filing date Nov 3, 2026
AESAES$15.020.00%
VRTX
Vertex said it acquired Crinetics in September 2026 for $85.00 per share in cash, with a total equity value of $10.0 billion and a net value of $9.0 billion after deducting cash, cash equivalents and marketable securities acquired. The company said it funded the deal with cash on hand and marketable securities, plus $4.5 billion in proceeds from the 2026 Term Loan.
US filing analysisUS10-Q · Quarterly reportPublished Nov 3, 2026 (UTC)SEC filing date Nov 3, 2026
Vertex PharmaceuticalsVRTX$515.02-1.08%
ZBRA
The company said net sales for the quarter ended October 3, 2026 were $1,614 million, up 22.3% from $1,320 million in the prior-year quarter. It said operating income was $237 million ($183 million in the prior-year quarter) and diluted earnings per share were $3.43 ($1.97 in the prior-year quarter).
US filing analysisUS10-Q · Quarterly reportPublished Nov 3, 2026 (UTC)SEC filing date Nov 3, 2026
Zebra TechnologiesZBRA$301.57-3.50%
ADM
ADM said earnings before income taxes for the quarter ended September 30, 2026 rose to $997 million from $147 million in the same quarter last year. The company said the prior-year quarter included impairment, exit, restructuring costs, penalty charges, and revaluation losses of $409 million.
US filing analysisUS10-Q · Quarterly reportPublished Nov 3, 2026 (UTC)SEC filing date Nov 3, 2026
Archer-Daniels-MidlandADM$66.95-0.27%
UDR
The company said net income available to common stockholders for the 3 months ended September 30, 2026 was $214.9 million ($0.67 per diluted share), compared with $39.2 million ($0.12 per share) a year earlier. The company cited gains on real estate dispositions of $190.1 million as one of the factors behind the increase.
US filing analysisUS10-Q · Quarterly reportPublished Nov 3, 2026 (UTC)SEC filing date Nov 3, 2026
UDRUDR$35.45+0.34%
HSIC
The company said global net sales rose 4.0% for the 3 months ended September 26, 2026. In the same 3 months, Global Technology net sales increased 5.2%, and internally generated growth in local currency for the segment was 6.5%.
US filing analysisUS10-Q · Quarterly reportPublished Nov 3, 2026 (UTC)SEC filing date Nov 3, 2026
Henry ScheinHSIC$83.5-1.53%
PNC
The company said net income for Q3 2026 was $2.1 billion ($4.97 per diluted common share), up $42 million (2%) from the prior quarter. It said net interest income rose to $4.2 billion, up $99 million, and net interest margin fell to 2.94%, down 2 basis points.
US filing analysisUS10-Q · Quarterly reportPublished Nov 3, 2026 (UTC)SEC filing date Nov 3, 2026
PNC Financial ServicesPNC$213.12-2.24%
DD
The company said net sales for the 3 months ended September 30, 2026 rose to $1.9 billion from $1.8 billion a year earlier, up 4%, with 5% organic sales growth partly offset by a 1% unfavorable currency impact.
US filing analysisUS10-Q · Quarterly reportPublished Nov 3, 2026 (UTC)SEC filing date Nov 3, 2026
DuPontDD$145.43-2.85%
IVZ
The company said it recorded net long-term inflows of $35.1 billion and global liquidity net inflows of $47.0 billion in Q3 2026. Average AUM was $2.5 trillion, an increase of $449.8 billion (21.8%) from the same period a year earlier.
US filing analysisUS10-Q · Quarterly reportPublished Nov 3, 2026 (UTC)SEC filing date Nov 3, 2026
InvescoIVZ$26.51-4.54%
AME
AMETEK said its net sales for Q3 2026 were $2,220.3 million, an increase of $327.7 million (17.3%) from $1,892.6 million for Q3 2025. The company attributed the increase to 10% organic sales growth and a 7% contribution from acquisitions.
US filing analysisUS10-Q · Quarterly reportPublished Nov 3, 2026 (UTC)SEC filing date Nov 3, 2026
AMETEKAME$222.9-3.57%
ABBV
The company said it recorded worldwide net revenues of $49.4 billion, operating earnings of $16.7 billion, diluted earnings per share of $4.79 and cash flows from operations of $14.9 billion for the 9 months ended September 30, 2026. Net revenues rose 11% on a reported basis and 10% on a constant currency basis.
US filing analysisUS10-Q · Quarterly reportPublished Nov 3, 2026 (UTC)SEC filing date Nov 3, 2026
AbbVieABBV$286.2+0.94%
MPC
The company said Marathon Petroleum net income attributable to MPC was $7.45 billion ($26.59 per diluted share) for Q3 2026, compared with $1.37 billion ($4.51 per share) for Q3 2025. Year-to-date through 2026 January–September, it was $13.10 billion ($45.40 per share).
US filing analysisUS10-Q · Quarterly reportPublished Nov 3, 2026 (UTC)SEC filing date Nov 3, 2026
Marathon PetroleumMPC$370.77+0.77%
PFE
The company said total revenues for Q3 2026 decreased $71 million to $16.6 billion, and total revenues for the 9-month period increased 2% to $46.1 billion. It said that excluding Comirnaty and Paxlovid, total revenues increased 7% operationally.
US filing analysisUS10-Q · Quarterly reportPublished Nov 3, 2026 (UTC)SEC filing date Nov 3, 2026
PfizerPFE$27.4-0.51%
ECHO
The company said it closed the AT&T Transactions on July 28, 2026, selling 3.45 GHz and 600 MHz Licenses and receiving $20.250 billion in cash from AT&T. Separately, AT&T directly remitted $2.4 billion into the Wireless Creditor Trust.
US filing analysisUS10-Q · Quarterly reportPublished Nov 3, 2026 (UTC)SEC filing date Nov 3, 2026
EchoStarECHO$84.3-8.68%
PNW
The company said net income attributable to common shareholders for the 3-month period ended September 30, 2026 was $434 million, up about $21 million from $413 million a year earlier. It cited higher customer usage and growth and weather effects as factors that increased earnings, while higher depreciation and interest expense and lower other income partly offset them.
US filing analysisUS10-Q · Quarterly reportPublished Nov 3, 2026 (UTC)SEC filing date Nov 3, 2026
Pinnacle West CapitalPNW$101.28-0.73%
IT
The company said total revenues for Q3 2026 were $1.5 billion, down 1% from a year earlier, and net income was $214.4 million ($35.4 million a year earlier). It cited the goodwill impairment loss in 2025 as the reason net income increased.
US filing analysisUS10-Q · Quarterly reportPublished Nov 3, 2026 (UTC)SEC filing date Nov 3, 2026
GartnerIT$174.49+1.27%
PLTR
The company recorded revenue of $2.3 billion for the 3 months ended September 30, 2026, up 96% from the same period in 2025 when it recorded $1.2 billion. Revenue for the 9 months to date totaled $5.9 billion, up 92%.
US filing analysisUS10-Q · Quarterly reportPublished Nov 3, 2026 (UTC)SEC filing date Nov 3, 2026
Palantir TechnologiesPLTR$143.49-6.63%
O
The company said it invested $2.6 billion in the 3 months ended September 30, 2026, with its pro-rata share at $2.2 billion and an initial weighted average cash yield of 6.8%. In the 9 months, it invested $7.9 billion, with its pro-rata share at $6.9 billion and a yield of 7.1%.
US filing analysisUS10-Q · Quarterly reportPublished Nov 3, 2026 (UTC)SEC filing date Nov 3, 2026
Realty IncomeO$58.03+0.64%
BSX
The company said a cybersecurity incident identified in August 2026 caused disruptions to global operations, including manufacturing and processing and shipping customer orders, and that it materially impacted its financial results for Q3.
US filing analysisUS10-Q · Quarterly reportPublished Nov 2, 2026 (UTC)SEC filing date Nov 2, 2026
Boston ScientificBSX$41.98-2.35%
CLX
Clorox said net sales for the quarter ended September 30, 2026 rose 33% from the year-ago period, and volume rose 31%. The company cited lapping lower shipments in the prior year after incremental shipments tied to the ERP transition, and the benefit of the GOJO acquisition, as the main factors.
US filing analysisUS10-Q · Quarterly reportPublished Nov 2, 2026 (UTC)SEC filing date Nov 2, 2026
CloroxCLX$104.73-0.16%
PEG
The company said net income declined for the Q3 2026 and the 9 months, mainly because of 2026 MTM losses (compared with gains in the prior year) and lower net gains on NDT Fund investments. It cited increased investment in PSE&G's T&D clause programs and higher capacity revenues at PSEG Power as partial offsets.
US filing analysisUS10-Q · Quarterly reportPublished Nov 2, 2026 (UTC)SEC filing date Nov 2, 2026
Public Service Enterprise GroupPEG$73.9-0.28%
GS
The company said net earnings for Q3 2026 were $5.29 billion, up from $4.10 billion for Q3 2025, and diluted earnings per share (EPS) were $17.01 for Q3 2025 versus $12.25, with annualized return on equity (ROE) at 18.7% compared with 14.2%.
US filing analysisUS10-Q · Quarterly reportPublished Nov 2, 2026 (UTC)SEC filing date Nov 2, 2026
Goldman SachsGS$796.5-6.02%
These reports are reference information based on public facts such as filings and prices. They do not recommend buying or selling any security.